ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 893,98
0,00%
Dow Jones
38 868,04
0,18%
DAX
18 494,89
-0,33%
Brent Oil
81,305
-0,57%
Bitcoin
67 894,43
-2,32%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. CNBX Pharmaceuticals Inc (QB) (CNBX)

  7. CNBX Pharmaceuticals Inc (QB) (CNBX) Actualités

CNBX

CNBX Pharmaceuticals (QB) (CNBX)

CNBX Pharmaceuticals Inc (QB)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:CNBX
DateHeureSourceTitreSymboleSociété
13/02/202422h27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
12/01/202416h13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
14/04/202315h59Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
06/03/202323h04Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
08/02/202313h51Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
27/12/202213h50Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
18/02/202222h02Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
04/02/202214h26Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
18/05/202112h07Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
23/02/202121h28Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
04/11/202017h22Edgar (US Regulatory)Annual Report (10-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
14/01/201923h01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
26/09/201814h06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
12/09/201815h11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
29/11/201721h38Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
25/10/201714h45InvestorWireBiotechs Develop Proprietary Systems to Drive CBD Research and DevelopmentUSOTC:CNBXCNBX Pharmaceuticals Inc (QB)
31/08/201704h29InvestorsHub NewsWireMJAC 2017 Speaker Update - How venture capital and cryptocurrency are converging as the future of cannabis investingUSOTC:CNBXCNBX Pharmaceuticals Inc (QB)
28/08/201716h43InvestorsHub NewsWirePotNetwork Holdings, Inc Confirmed for MJAC 2017USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
26/08/201700h50InvestorsHub NewsWireMJAC 2017 International Cannabis Conference - Discount CodeUSOTC:CNBXCNBX Pharmaceuticals Inc (QB)
23/08/201718h50InvestorsHub NewsWireBook your ticket now for InvestorsHubs International Cannabis ConferenceUSOTC:CNBXCNBX Pharmaceuticals Inc (QB)
22/08/201707h27InvestorsHub NewsWireMJAC 2017 - Speaker Update - Investing In The U.S. Cannabis MarketUSOTC:CNBXCNBX Pharmaceuticals Inc (QB)
20/04/201715h00InvestorsHub NewsWireWhat Cannabis Stocks Investors Should Know and Coverage of a Mobile Tech Sub Penny StockUSOTC:CNBXCNBX Pharmaceuticals Inc (QB)
07/04/201715h44Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
21/03/201718h18Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
15/03/201717h52Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
08/02/201714h30InvestorWireIsraeli Innovation is at the Heart of a Growing Cannabis EcosystemUSOTC:CNBXCNBX Pharmaceuticals Inc (QB)
21/12/201620h05Edgar (US Regulatory)Report of Proposed Sale of Securities (144)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
08/04/201612h02Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
11/07/201421h37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
01/05/201412h08Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
 Showing the most relevant articles for your search:USOTC:CNBX

Dernières Valeurs Consultées

BIT
P1U6M9
BNP Paribas Issuance
BIT
P1L5U5
BNP Paribas Issuance
NEO
GLDE
Ninepoint Gold and Preci...
LSE
AA51
Citi Fun 29
USOTC
INCPF
Innocare Pharma (PK)
LATK
CSTV2USDT
CRYPTO STREET V2
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés